FrankWallaceLeeMD

PubMed

• Inhibition of hepatic organic anion-transporting polypeptide by RNA interference in sandwich-cultured human hepatocytes: an in vitro model to assess transporter-mediat...
  Liao, M., Raczynski, A.R., Chen, M., Chuang, B., Zhu, Q., Shipman, R., Morrison, J., Lee, D., Lee, F.W., Balani, S.K., Xia, C.Q.> ;Drug Metab Dispos. 2010 Sep
• Prediction of pharmacokinetic drug-drug interactions using human hepatocyte suspension in plasma and cytochrome P450 phenotypic data. III. In vitro-in vivo correlation...
  Lu, C., Berg, C., Prakash, S.R., Lee, F.W., Balani, S.K.> ;Drug Metab Dispos. 2008 Jul
• Prediction of pharmacokinetic drug-drug interactions using human hepatocyte suspension in plasma and cytochrome P450 phenotypic data. II. In vitro-in vivo correlation ...
  Lu, C., Hatsis, P., Berg, C., Lee, F.W., Balani, S.K.> ;Drug Metab Dispos. 2008 Jul
• Role of P-glycoprotein and the intestine in the excretion of DPC 333 [(2R)-2-{(3R)-3-amino-3-[4-(2-methylquinolin-4-ylmethoxy)phenyl]-2-oxopyrrolidin-1-yl}-N-hydroxy-4...
  Garner, C.E., Solon, E., Lai, C., Lin, J., Luo, G., Jones, K., Duan, J., Decicco, C.P., Maduskuie, T., Mercer, S.E., Gan, L., Qian, M., Prakash, S., Shen, H., Lee, F.W.> ;Drug Metab Dispos. 2008 Jun
• Effect of DPC 333 [(2R)-2-{(3R)-3-amino-3-[4-(2-methylquinolin-4-ylmethoxy)phenyl]-2-oxopyrrolidin-1-yl}-N-hydroxy-4-methylpentanamide], a human tumor necrosis factor ...
  Luo, G., Garner, C.E., Xiong, H., Hu, H., Richards, L.E., Brouwer, K.R., Duan, J., Decicco, C.P., Maduskuie, T., Shen, H., Lee, F.W., Gan, L.> ;Drug Metab Dispos. 2007 Jun
• Evaluation of microdosing to assess pharmacokinetic linearity in rats using liquid chromatography-tandem mass spectrometry.
  Balani, S.K., Nagaraja, N.V., Qian, M.G., Costa, A.O., Daniels, J.S., Yang, H., Shimoga, P.R., Wu, J., Gan, L., Lee, F.W., Miwa, G.T.> ;Drug Metab Dispos. 2006 Mar
• Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in guinea pigs and mice using serial sampling.
  Balani, S.K., Li, P., Nguyen, J., Cardoza, K., Zeng, H., Mu, D., Wu, J., Gan, L., Lee, F.W.> ;Drug Metab Dispos. 2004 Oct
• Concurrent induction and mechanism-based inactivation of CYP3A4 by an L-valinamide derivative.
  Luo, G., Lin, J., Fiske, W.D., Dai, R., Yang, T.J., Kim, S., Sinz, M., LeCluyse, E., Solon, E., Brennan, J.M., Benedek, I.H., Jolley, S., Gilbert, D., Wang, L., Lee, F...> ;Drug Metab Dispos. 2003 Sep
• Interaction of ritonavir on tissue distribution of a [(14)c]L-valinamide, a potent human immunodeficiency virus-1 protease inhibitor, in rats using quantitative whole-...
  Solon, E.G., Balani, S.K., Luo, G., Yang, T.J., Haines, P.J., Wang, L., Demond, T., Diamond, S., Christ, D.D., Gan, L., Lee, F.W.> ;Drug Metab Dispos. 2002 Nov
• Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in rats, dogs, and monkeys.
  Balani, S.K., Zhu, T., Yang, T.J., Liu, Z., He, B., Lee, F.W.> ;Drug Metab Dispos. 2002 Oct
• An indirect screen for brain uptake of 1,2-diarylethane melanocortin 4 receptor antagonists in rats.
  Yin, W., Gan, L. S., Wu, J. T., Balani, S. K., Yang, H., Lee, F. W.> ;Drug Metab Lett. 2007 Aug 01
• P-glycoprotein and breast cancer resistance protein affect disposition of tandutinib, a tyrosine kinase inhibitor.
  Yang, J. J., Milton, M. N., Yu, S., Liao, M., Liu, N., Wu, J. T., Gan, L., Balani, S. K., Lee, F. W., Prakash, S., Xia, C. Q.> ;Drug Metab Lett. 2010 Dec
• Proposed new addition to 3Rs for ethical and humane use of rats in pharmacokinetic studies--''Recycle''.
  Balani, S. K., Lu, C., Cardoza, K., Berg, C., Zhang, J., Lee, F. W.> ;Drug Metab Lett. 2008 Aug 01
• Strategy of utilizing in vitro and in vivo ADME tools for lead optimization and drug candidate selection.
  Balani, S. K., Miwa, G. T., Gan, L. S., Wu, J. T., Lee, F. W.> ;Curr Top Med Chem. 2005
• Join now to see all